Insiders · Profile

Birznieks Gunther

SVP, Business Development at Vanda Pharmaceuticals. Filing since 2 Jan 2018. CIK 0001702031

Company

Date

Role

Action

Shares

Amount

Of holding

VNDA Vanda Pharmaceuticals Inc.

2 Mar 2026

SVP, Business Development

Sold at will

42,431

$350.73K

7.9%

VNDA Vanda Pharmaceuticals Inc.

5 Mar 2024

SVP, Business Development

Sold at will

8,684

$35.88K

2.7%

VNDA Vanda Pharmaceuticals Inc.

4 Mar 2024

SVP, Business Development

Sold at will

8,727

$37.49K

2.6%

VNDA Vanda Pharmaceuticals Inc.

3 Mar 2023

SVP, Business Development

Sold, plan not stated

8,268

$51.79K

3.9%

VNDA Vanda Pharmaceuticals Inc.

2 Mar 2023

SVP, Business Development

Sold, plan not stated

8,509

$52.79K

3.8%

VNDA Vanda Pharmaceuticals Inc.

2 Mar 2022

SVP, Business Development

Sold, plan not stated

11,517

$129.79K

5.7%

VNDA Vanda Pharmaceuticals Inc.

1 Mar 2022

SVP, Business Development

Sold, plan not stated

4,084

$45.70K

2.0%

VNDA Vanda Pharmaceuticals Inc.

2 Mar 2021

SVP, Business Development

Sold, plan not stated

16,620

$302.27K

8.8%

VNDA Vanda Pharmaceuticals Inc.

1 Mar 2021

SVP, Business Development

Sold, plan not stated

3,845

$71.74K

2.0%

VNDA Vanda Pharmaceuticals Inc.

3 Mar 2020

SVP, Business Development

Sold, plan not stated

5,535

$58.98K

3.4%

VNDA Vanda Pharmaceuticals Inc.

2 Mar 2020

SVP, Business Development

Sold, plan not stated

12,223

$122.69K

6.9%

VNDA Vanda Pharmaceuticals Inc.

2 Jan 2020

SVP, Business Development

Sold, plan not stated

4,020

$64.02K

2.7%

VNDA Vanda Pharmaceuticals Inc.

4 Mar 2019

SVP, Business Development

Sold, plan not stated

8,788

$174.77K

5.5%

VNDA Vanda Pharmaceuticals Inc.

1 Mar 2019

SVP, Business Development

Sold, plan not stated

3,741

$75.33K

2.3%

VNDA Vanda Pharmaceuticals Inc.

3 Jan 2019

SVP, Business Development

Sold, plan not stated

1,619

$42.23K

1.2%

VNDA Vanda Pharmaceuticals Inc.

2 Jan 2019

SVP, Business Development

Sold, plan not stated

4,442

$117.58K

3.2%

VNDA Vanda Pharmaceuticals Inc.

1 Mar 2018

SVP, Business Development

Sold, plan not stated

8,525

$159.61K

5.7%

VNDA Vanda Pharmaceuticals Inc.

2 Jan 2018

SVP, Business Development

Sold, plan not stated

8,568

$130.78K

6.8%

18 decisions on file.